TrialThe British journal of ophthalmology2014

A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysis.

Rishi P Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.